Wendy Y. Cheng - Concepedia

Author

Wendy Y. Cheng

Also Known As

Cheng, Wendy, Cheng, Wendy Y., Cheng, Wendy Yin Kei, Man Ho, W Y Cheng, W. Cheng, W. Y. Cheng, W.Y. Cheng, Wendy Cheng, Wendy Cheng, MPH, MPhil

134

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Analysis Group (United States)Columbia University Group for Research in Decision Analysis New York State Psychiatric Institute New York State Office of Alcoholism and Substance Abuse Services

About

Wendy Y. Cheng is an author at Analysis Group (United States) specializing in medicine, addiction, and substance abuse.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	476
2	Health Sciences	5	5	363
3	Public Health	3	3	48
4	Social Sciences	2	2	55
5	Behavioral Sciences	1	1	30

Wendy Y. Cheng

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Dronabinol for the treatment of cannabis dependence: A randomized, double-blind, placebo-controlled trial Frances R. Levin, John J. Mariani, Daniel J. Brooks, Drug and Alcohol Dependence Cannabis UseSubstance AbusePsychoactive DrugSubstance UseHealth Sciences	2011	217
A Preliminary Trial: Double‐Blind Comparison of Nefazodone, Bupropion‐SR, and Placebo in the Treatment of Cannabis Dependence Kenneth M. Carpenter, David M. McDowell, Daniel J. Brooks, American Journal on Addictions	2009	88
Comorbidities and Survival in Patients With Lipodystrophy: An International Chart Review Study Elif A Oral, Adam Neidert, Diana Rus, The Journal of Clinical Endocrinology & Metabolism	2019	76
“Old dogs” and new skills: How clinician characteristics relate to motivational interviewing skills before, during, and after training. Kenneth M. Carpenter, Wendy Y. Cheng, Jennifer L. Smith, Journal of Consulting and Clinical Psychology	2012	68
A placebo-controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in period Adam Bisaga, Efrat Aharonovich, Wendy Y. Cheng, Drug and Alcohol Dependence Cocaine DependenceSubstance AbuseSubstance UsePre-randomization Lead-in PeriodAddiction	2010	61
Real-world outcomes in patients with metastatic castration-resistant prostate cancer receiving second-line chemotherapy versus an alternative androgen receptor-targeted agent (ARTA) following early progression on a first-line ARTA in a US community oncology setting William Oh, Wendy Y. Cheng, Raymond Miao, Urologic Oncology Seminars and Original Investigations	2018	56
Atomoxetine Treatment for Cocaine Abuse and Adult Attention Deficit/Hyperactivity Disorder (ADHD): A Preliminary Open Trial Frances R. Levin, John J. Mariani, Alex Secora, Journal of Dual Diagnosis Adhd SymptomsPsychotropic MedicationPsychopharmacologyDrug TreatmentPreliminary Open Trial	2009	44
The association between naltrexone treatment and symptoms of depression in opioid-dependent patients David J. Mysels, Wendy Y. Cheng, Edward V. Nunes, The American Journal of Drug and Alcohol Abuse	2010	38
A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependence Adam Bisaga, Maria A. Sullivan, Wendy Y. Cheng, Drug and Alcohol Dependence Opioid DependenceSubstance AbuseAddictionPharmacologyNeuropharmacology	2011	35
Adherence to iron chelation therapy and associated healthcare resource utilization and costs in Medicaid patients with sickle cell disease and thalassemia Francis Vekeman, Medha Sasané, Wendy Y. Cheng, Journal of Medical Economics	2015	33

Page 1